Evidence map›Paper›PMID 25325355›Full record

ArticleInternational journal of environmental research and public health2014

Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status.

Brian Downer, Steven Estus, Yuriko Katsumata, David W Fardo

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Characteristics of Dyslipidemia in Adults With Resistance to Thyroid Hormone β.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Article
  3. Resveratrol, a calorie restriction mimetic, protects AlClNaunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  4. Article
  5. Article
  6. Scientific opinion on the tolerable upper intake level for vitamin E.EFSA journal. European Food Safety Authority · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Brian DownerSealy Center on Aging, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. brdowner@utmb.edu.
Steven EstusDepartment of Physiology, College of Medicine, University of Kentucky, 138 Leader Avenue, Lexington, KY 40506, USA. steve.estus@uky.edu.
Yuriko KatsumataDepartment of Biostatistics, College of Public Health, University of Kentucky, Suite 205, 725 Rose Street, Lexington, KY 40536, USA. katsumata.yuriko@uky.edu.
David W FardoSanders-Brown Center on Aging, University of Kentucky, 101 Sanders-Brown Building, 800 S. Limestone Street, Lexington, KY 40536, USA. david.fardo@uky.edu.
University of Kentucky · USThe University of Texas Medical Branch at Galveston · US

Funding

TRANSGENIC MOUSE COREP01AG030128 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BU, GUOJUN · 2009 to 2013
$9.4M
Translating CD33 genetic mechanism into a novel Alzheimers therapeuticR01AG045775 · NIA · UNIVERSITY OF KENTUCKY · PI ESTUS, STEVEN · 2014 to 2017
$1.2M
Statistical Genetics Methods for Mixed PathologiesK25AG043546 · NIA · UNIVERSITY OF KENTUCKY · PI FARDO, DAVID WILLIAM · 2013 to 2015
$445k
NIA NIH HHS K25 AG043546NIA NIH HHS K25AG043546NIA NIH HHS P01 AG030128NIA NIH HHS R01 AG045775NIA NIH HHS R01AG-045775
6 · The paper itself

Abstract

backgroundPrevious research indicates that total cholesterol levels increase with age during young adulthood and middle age and decline with age later in life. This is attributed to changes in diet, body composition, medication use, physical activity, and hormone levels. In the current study we utilized data from the Framingham Heart Study Original Cohort to determine if variations in apolipoprotein E (APOE), a gene involved in regulating cholesterol homeostasis, influence trajectories of total cholesterol, HDL cholesterol, and total: HDL cholesterol ratio from midlife through late life.

methodsCholesterol trajectories from midlife through late life were modeled using generalized additive mixed models and mixed-effects regression models.

resultsAPOE e2+ subjects had lower total cholesterol levels, higher HDL cholesterol levels, and lower total: HDL cholesterol ratios from midlife to late life compared to APOE e3 and APOE e4+ subjects. Statistically significant differences in life span cholesterol trajectories according to gender and use of cholesterol-lowering medications were also detected.

conclusionThe findings from this research provide evidence that variations in APOE modify trajectories of serum cholesterol from midlife to late life. In order to efficiently modify cholesterol through the life span, it is important to take into account APOE allele status.

Indexed as

AdultAgedAged, 80 and overAgingAnticholesteremic AgentsApolipoproteins ECholesterolCholesterol, HDLFemaleHumansLongitudinal StudiesMaleMiddle AgedPolymorphism, GeneticSex FactorsAnticholesteremic AgentsApolipoproteins ECholesterolCholesterol, HDL

Identifiers

PMID25325355
PMCPMC4211000
OpenAlexW1992938355

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.